Results 1 to 10 of about 4,597 (221)
Macrophage Polarization during MRONJ Development in Mice [PDF]
Macrophages are important regulators of bone remodeling, and M1 polarization is observed in the setting of medication-related osteonecrosis of the jaws (MRONJ). Here, we characterize the phenotype of macrophages during early stages of MRONJ development in zoledronate (ZA)–treated mice with periodontal disease and explore the role of rosiglitazone, a ...
Akrivoula Soundia +7 more
semanticscholar +4 more sources
On 24 February 2024, Italian physicians, dentists and oral care specialists, students, nurses, psychologists, dental hygienists, and other professionals met (live or online) to discuss controversial issues about medication-related osteonecrosis of the ...
Vittorio Fusco +8 more
doaj +3 more sources
Clinical and Radiological Evaluation of Oral and Maxillofacial Status in Patients Undergoing Antiresorptive Therapy and Its Relationship with MRONJ [PDF]
Background/Objectives: Patients undergoing antiresorptive therapy were evaluated, focusing on clinical and radiological features and their relationship with medication-related osteonecrosis of the jaw (MRONJ).
Marcela Wiltgen Jeffman +5 more
doaj +2 more sources
Clinical outcome and volumetric 3D analysis of biofluorescence imaging system guided surgery for Medication-Related Osteonecrosis of the Jaw(MRONJ) [PDF]
This study aims to evaluate the clinical outcome of biofluorescent imaging system (BIS) guided MRONJ surgery through analyzing 3D volumetric changes in CBCT data of bone structure.
Sooshin Hwang +5 more
openalex +2 more sources
Background: Medication related osteonecrosis of the jaw (MRONJ) is a chronic condition of the oral cavity resulting in mucosal ulceration and exposure of underlying necrotic bone, and the ensuing secondary complications.
Gholamreza Shirani +5 more
doaj +2 more sources
Background Medication-Related Osteonecrosis of the Jaw (MRONJ), an established side effect of antiresorptive and antiangiogenic medication, could sometimes require surgical intervention, such as decortication. The objectives of this retrospective patient
Oliver Bissinger +6 more
doaj +2 more sources
Medication-related osteonecrosis of the jaw (MRONJ) is a debilitating condition associated with antiresorptive and antiangiogenic medications that are frequently used in treating osteoporosis and cancers.
Yui Yin Ko, Wei-Fa Yang, Yiu Yan Leung
doaj +2 more sources
Siqi Zhu,1– 3,* Yajun Cui,2,3,* Weidong Zhang,2,3 Yu Ji,2,3 Lingshuang Li,2,3 Shenglei Luo,4 Jing Cui,5,6 Minqi Li2,3 1School of Stomatology, Jinzhou Medical University, Jinzhou, People’s Republic of China; 2Department of Bone Metabolism, School ...
Zhu S +7 more
doaj +2 more sources
Objective Medication-related osteonecrosis of the jaw bones (MRONJ) is a well-known complication of antiresorptive and antiangiogenic drugs. Since the first report, more occurrences of MRONJ have been described worldwide.
Kamila Alblazi +4 more
doaj +2 more sources
Endodontic treatment and management of patients under antiresorptive treatment: a scoping review on MRONJ risk. [PDF]
To summarize the current scientific evidence on the implications of root canal treatment (RCT) in patients receiving antiresorptive therapy and to outline best practices for managing such cases to prevent MRONJ.
Zavalloni G +8 more
europepmc +2 more sources

